›› 2010, Vol. 5 ›› Issue (02): 119-122.

• 论著 • 上一篇    下一篇

重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中的预后与溶栓后动脉收缩压变化的关系

张新宇,王丽平,樊东升,沈扬,李小刚   

  1. 北京市北京大学第三医院神经内科
  • 收稿日期:2009-05-27 修回日期:2009-04-27 出版日期:2010-02-20 发布日期:2010-02-20
  • 通讯作者: 李小刚

The Relationship between the Clinical Outcomes and Changes of Systolic Pressure in Early Stage after Thrombolysis Treatment Using rt-PA in Patients with Ultra-Acute Cerebral Infarction

ZHANG Xin-Yu, WANG Li-Ping, FAN Dong-Sheng, et al.   

  • Received:2009-05-27 Revised:2009-04-27 Online:2010-02-20 Published:2010-02-20
  • Contact: LI Xiao-Gang

摘要: 目的 探讨重组组织型纤溶酶原激活剂(recombinant tissue plasminogen activator,rt-PA)静脉溶栓治疗缺血性卒中的预后与溶栓后24h及72h动脉收缩压变化的关系,研究血压变化规律作为提示溶栓预后早期指标的可能。方法 用回顾性研究方法,对112例接受了rt-PA静脉溶栓治疗的超早期缺血性卒中患者按90d的预后分为预后不良(改良Rankin评分2~5)和预后良好(改良Rankin评分0~1)两组,比较这两组患者在溶栓前及治疗后24h及72h的动脉收缩压变化情况。结果 预后不良组溶栓治疗后24h收缩压降低为(7±8)mmHg,而预后良好组同期为(10±8)mmHg,两组间比较差异有统计学意义(P <0.05)。预后不良组溶栓后72h收缩压降低为(8±8)mmHg,预后良好组为(10±8)mmHg,两组间比较差异无统计学意义(P >0.05)。结论 预后良好组溶栓治疗后24h内动脉收缩压下降幅度明显高于预后不良组,而溶栓后72h这种差异已经不明显。溶栓后24h收缩压的明显下降可能与溶栓治疗90d时的良好预后相关。

关键词: 纤溶酶原激活剂; 血栓溶解疗法; 血压; 预后

Abstract: Objective To investigate the relationship between the clinical outcomes of thrombolysis treatmentusing recombinant tissue plasminogen activator (rt-PA) in patients with ultra-acute cerebralinfarction and the changes of systolic pressure in 24h and 72h after treatment.Methods One hundred and twelve patients with ultra-acute cerebral infarction treated byintravenous rt-PA were assigned to the poor outcome group[90d modified Rankin Score (mRS) 2-5]and the good outcome group (90d mRS 0-1). The changes of systolic pressure of enrolled patientswere recorded at time of pre-treatment and 24h and 72h post-treatment respectively. Then thesechanges were compared between two groups.Results The decreases of systolic pressure in 24h after treatment in poor outcome group was (7±8)mmHg, comparing with the (10±8) mmHg in good outcome group. There was a statisticallysignificant difference (t =-2.20, P =0.032) of systolic blood pressure variety between the two groups.The decreases of systolic pressure in 72h post-treatment in the two groups were (8±8)mmHg and(10±8)mmHg respectively. There was not a statistically significant difference (t =-1.52, P =0.13)between two groups.Conclusion The descending of systolic blood pressure in 24h after thrombolysis treatment ingood outcomes group was more obvious than that in poor outcomes group. But this difference didnot appear in 72h post-treatment. The degree of the systolic pressure decreasing in 24h after rt-PAthrombolysis potentially was related positively with benign prognosis after 90d.

Key words: Plasminogen activators; Thrombolytic therapy; Blood pressure; Prognosis